Page last updated: 2024-09-05

dabigatran and Abnormality, Heart

dabigatran has been researched along with Abnormality, Heart in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Beauchesne, LM; Bouma, BJ; Khairy, P; Macle, L; Mongeon, FP; Mulder, BJM; Schwerzmann, M	1
Dellborg, M; Mandalenakis, Z	1

Reviews

1 review(s) available for dabigatran and Abnormality, Heart

Article	Year
Non-Vitamin K Antagonist Oral Anticoagulants in Adult Congenital Heart Disease. The Canadian journal of cardiology, 2019, Volume: 35, Issue:12 Topics: Administration, Oral; Adult; Age Factors; Anticoagulants; Antithrombins; Atrial Fibrillation; Blood Coagulation; Dabigatran; Female; Heart Defects, Congenital; Heart Valve Diseases; Humans; Male; Prognosis; Pyrazoles; Pyridines; Pyridones; Risk Assessment; Severity of Illness Index; Sex Factors; Stroke; Survival Analysis; Thiazoles; Vitamin K	2019

Article

Year

Non-Vitamin K Antagonist Oral Anticoagulants in Adult Congenital Heart Disease.

The Canadian journal of cardiology, 2019, Volume: 35, Issue:12

Topics: Administration, Oral; Adult; Age Factors; Anticoagulants; Antithrombins; Atrial Fibrillation; Blood Coagulation; Dabigatran; Female; Heart Defects, Congenital; Heart Valve Diseases; Humans; Male; Prognosis; Pyrazoles; Pyridines; Pyridones; Risk Assessment; Severity of Illness Index; Sex Factors; Stroke; Survival Analysis; Thiazoles; Vitamin K

2019

Other Studies

1 other study(ies) available for dabigatran and Abnormality, Heart

Article	Year
NOACs in adult congenital heart disease - Still limited experience. International journal of cardiology, 2020, 02-01, Volume: 300 Topics: Administration, Oral; Adult; Anticoagulants; Atrial Fibrillation; Dabigatran; Heart Defects, Congenital; Humans	2020